Wellington Management Group
HUMA icon

Wellington Management Group’s Humacyte HUMA Stock Holding History

Wellington Management Group’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-310,777
Closed -$530K – 1990
2025
Q1 		$530K Buy
310,777
+56,042
+22% +$210K ﹤0.01% 1814
2024
Q4 		$1.29M Buy
254,735
+324
+0.1% +$1.6K ﹤0.01% 1672
2024
Q3 		$1.38M Buy
254,411
+60,087
+31% +$396K ﹤0.01% 1652
2024
Q2 		$933K Sell
194,324
-3,740
-2% -$19.5K ﹤0.01% 1691
2024
Q1 		$616K Buy
+198,064
New +$666K ﹤0.01% 1781

Other funds holding HUMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wellington Management Group's HUMA Position: Q2 2025 in Review

Wellington Management Group sold out of Humacyte (HUMA) in Q2 2025, closing a stake of 310,777 shares — an estimated $530K sold.

Wellington Management Group first reported a position in HUMA in Q1 2024 and held it in 5 quarters. The position peaked at $1.38M in Q3 2024. 156 funds tracked by Wall St. Rank hold HUMA as of Q2 2025.

  • Wellington Management Group reported no remaining Humacyte position as of Q2 2025 after selling out during the quarter.
  • Wellington Management Group sold 310,777 Humacyte shares in Q2 2025, an estimated $530K.
  • Wellington Management Group first reported a position in Humacyte in Q1 2024 and held it in 5 quarters.
  • Wellington Management Group's Humacyte position peaked at $1.38M in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Humacyte as of Q2 2025.

Based on Wellington Management Group's 13F filing for Q2 2025, filed 14 Aug 2025.